Intrinsic Value of S&P & Nasdaq Contact Us

Relay Therapeutics, Inc. RLAY

NASDAQ Global Market

SharesGrow Score
52/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$16.33
+10.7%

Relay Therapeutics, Inc. (RLAY) current share price is $14.75. The gold spot price is $4,808.10 per troy ounce. Using the formula: RLAY in gold = $14.75 × 31.1035 ÷ $4,808.10 = 0.0954 grams of gold per share.

The Real Wealth Growth Rate measures the Compound Annual Growth Rate (CAGR) of RLAY when denominated in gold. A positive rate means the stock has outperformed gold as a store of value, while a negative rate indicates gold has been a better wealth preserver than holding RLAY shares over the measured period.

RLAY in US Dollars
Gold in US Dollars
RLAY in Gold (grams per share)

Real Wealth Growth Rate

RLAY
Computing…

"Real Wealth Growth Rate" measures the annualised compound growth rate (CAGR) of a stock when priced in gold — hard money that cannot be printed. A positive value means genuine wealth creation. A negative value means purchasing power is shrinking, even if the dollar price rises.

Step 1 — Express share price in grams of gold
$$\text{RLAY}_{\text{gold}}(t) = \frac{P_{\text{RLAY}}(t) \times 31.1035}{P_{\text{gold}}(t)}$$
$P_\text{RLAY}$ = stock price in USD, $P_\text{gold}$ = gold spot in USD/troy oz, $31.1035$ = grams per troy ounce.
Step 2 — Real Wealth Growth Rate (CAGR in gold terms)
$$\text{Real Wealth Growth Rate} = \left(\frac{\text{RLAY}_{\text{gold}}^{(T)}}{\text{RLAY}_{\text{gold}}^{(0)}}\right)^{\!\frac{1}{T}} - 1$$
$\text{RLAY}_\text{gold}^{(0)}$ = initial gold-price, $\text{RLAY}_\text{gold}^{(T)}$ = current gold-price, $T$ = number of years. A positive result means the stock outpaces gold.

Real Wealth Growth Rate Rankings — 20 Years

Computing…

People Also View

BPMC
BPMC
Blueprint Medicines Corporation
$129.46
+0.14%
APLS
APLS
Apellis Pharmaceuticals, Inc.
$40.85
+0.02%
TERN
TERN
Terns Pharmaceuticals, Inc.
$52.68
+0.13%
MRTX
MRTX
Mirati Therapeutics, Inc.
$58.70
-0.17%
EWTX
EWTX
Edgewise Therapeutics, Inc.
$33.16
-2.01%
DAWN
DAWN
Day One Biopharmaceuticals, Inc.
$21.46
-0.14%
STOK
STOK
Stoke Therapeutics, Inc.
$35.86
+2.31%
MLYS
MLYS
Mineralys Therapeutics, Inc.
$27.32
+0.59%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message